Table 3 The MIC and MBC for various concentrations of LYZ2-SH3b, LYZ2, and vancomycin;
From: LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus
Compound | MRSA: ATCC 43,300 | MRSA: clinical isolate ST239 | ||
|---|---|---|---|---|
MIC (µg/ml) | MBC (µg/ml) | MIC (µg/ml) | MBC (µg/ml) | |
LYZ2 | ≥ 4 | 4 | ≥ 8 | 8 |
LYZ2-SH3b | ≥ 2 | 2 | ≥ 4 | 4 |
Vancomycin | ≥ 0.5 | 0.5 | ≥ 0.5 | 0.5 |